Grundfos expands in India
rundfos has officially opened Phase II of its manufacturing unit in Chennai, India. The 7000 sq m plant was built in 11 months with an investment of Rp176 million. Facilities include a 1000 sq m office area, a 300 KW test bed and service/training and logistics departments. For further information, visit www.grundfos.in and www.grundfos.com
Larox divests Larox Flowsys holding to Capillary OY
arox Corp has sold its 49% stake in Larox Flowsys Oy to Capillary Oy in a E3.5 million deal (see Pump Industry Analyst, November 2009). Larox Flowsys supplies pinch and knife gate valves and peristaltic pumps for abrasive, corrosive and other demanding shut-off, control and pumping applications serving process industries worldwide. In 2008 Larox Flowsys had net sales of approximately 16.6 million and employed 52 people. Production facilities are located in Lappeenranta, Finland. Larox Flowsys can use the Larox trademark and company name for the next three years. The sale will not affect the cooperation between Larox Corp and Larox Flowsys Oy.
SPX chairman, president and CEO Christopher Kearney. “The acquisition also further enhances our design competencies for the turnkey, scalable food processing systems. Food manufacturers are increasingly seeking these kinds of systems to help optimise the production quality, efficiency, reliability and scale of their operations.” Gerstenberg Schröder had fiscal 2009 revenues of approximately US$70 million. The company will now operate within SPX’s Flow Technology segment, which already includes APV, Bran + Luebbe, Johnson Pump, Plenty Mirrlees Pump and Waukesha Cherry Burrell pumps. For further information, visit www.spx.com, www.spxflowtechnology.com and www.gs-as.com
Torishima Pump posts strong gains in orders and net profit
n the nine months to 31 December 2009, Japan’s Torishima Pump Mfg Co Ltd has secured orders worth ¥49.7 billion, sales of ¥29.5 billion, operating profit of ¥1.7 billion, and net profit of ¥1.7 billion. This compares with orders of ¥38.0 billion, sales of ¥29.7 billion, operating profit of ¥1.7 billion and net profit of ¥1.3 billion for the same period a year earlier. Order backlog at 31 December 2009 was ¥70.7 billion, up from ¥57.5 billion at the end of 2008.
For further information, visit www.torishima.co.jp For further information, visit www.larox.com
SPX seals Gerstenberg Schröder acquisition
PX Corp has completed the acquisition of Gerstenberg Schröder A/S, a Danish manufacturer of food processing systems and components including pumps (see Pump Industry Analyst, January 2010). “The addition of Gerstenberg Schröder strengthens our growing process equipment business by expanding our global food processing technology, equipment offerings and systems capabilities,” said 16
Pump Industry Analyst
Europump 2010 Annual Meeting
egistration is now open for the Europump 2010 Annual Meeting and 50th Anniversary Celebration which will be held in Paris, France 26–29 May 2010. The Europump Annual Meeting is a chance to share experiences and exchange views on the development of the pump industry. For further information, visit www.europump-paris2010.com and www.profluid.org
Editorial Office: Elsevier Limited, The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, United Kingdom Tel: +44 (0)1865 843695 Fax: +44 (0)1865 843933 Web: www.pumpindustryanalyst.com Editor: Roisin Reidy E-mail: r.[email protected]
Production Support Manager: Lin Lucas E-mail: [email protected]
Publisher: Greg Valero E-mail: [email protected]
Subscription Information An annual subscription to Pump Industry Analyst includes 12 printed issues and online access for up to 5 users. Prices: 1120 for all European countries & Iran US$1256 for all countries except Europe and Japan ¥148 900 for Japan (Prices valid until 31 December 2010) To subscribe send payment to the address above. Tel: +44 (0)1865 843687/Fax: +44 (0)1865 834971/ Email: [email protected]
, or via www.pumpindustryanalyst.com. Subscriptions run for 12 months, from the date payment is received. Periodicals postage is paid at Rahway, NJ 07065, USA. Postmaster send all USA address corrections to: Pump Industry Analyst, 365 Blair Road, Avenel, NJ 07001, USA Permissions may be sought directly from Elsevier Rights & Permissions Department, PO Box 800, Oxford OX5 1DX, UK; phone: (+44) 1865 843830, fax: (+44) 1865 853333, email: [email protected]
elsevier.com. You may also contact Rights & Permissions directly through Elsevier’s home page (http://www.elsevier.com), selecting first ‘Customer Support’, then ‘General Information’, then Permissions Query Form’. In the USA, users may clear permissions and make payments through the Copyright Clearance Center, Inc., 222 Rosewood Drive, Danvers, MA 01923, USA; phone: (978) 7508400, fax: (978) 7504744, and in the UK through the Copyright Licensing Agency Rapid Clearance Service (CLARCS), 90 Tottenham Court Road, London W1P 0LP, UK; phone: (+44) 207 436 5931; fax: (+44) 207 436 3986. Other countries may have a local reprographic rights agency for payments. Derivative Works Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the publisher is required for resale or distribution outside the institution. Permission of the publisher is required for all other derivative works, including compilations and translations. Electronic Storage or Usage Permission of the publisher is required to store or use electronically any material contained in this journal, including any article or part of an article. Contact the publisher at the address indicated. Except as outlined above, no part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the publisher. Address permissions requests to: Elsevier Rights & Permissions Department, at the mail, fax and email addresses noted above. Notice No responsibility is assumed by the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.
Printed by Mayfield Press (Oxford) LImited 02167